MARKET

HBIO

HBIO

Harvard
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.83
-0.14
-2.01%
After Hours: 6.83 0 0.00% 17:27 04/19 EDT
OPEN
7.02
PREV CLOSE
6.97
HIGH
7.05
LOW
6.70
VOLUME
165.49K
TURNOVER
--
52 WEEK HIGH
7.14
52 WEEK LOW
2.060
MARKET CAP
272.70M
P/E (TTM)
-33.6619
1D
5D
1M
3M
1Y
5Y
Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET
HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6, 2021, and will hold a conference call to discuss the r...
GlobeNewswire · 9h ago
Global Bioreactor Perfusion Systems Market Insights, Overview, Analysis and Forecast 2021-2026
Apr 19, 2021 (Heraldkeepers) -- The Bioreactor Perfusion Systems market report provides a detailed analysis of global market size, regional and country-level...
Heraldkeepers · 1d ago
Electrophoresis Market Research Report by Device, by Service, by Industry – Global Forecast to 2025 – Cumulative Impact of COVID-19
Apr 07, 2021 (Heraldkeepers) -- The global Electrophoresis market report provides geographic analysis covering regions, such as North America, Europe,...
Heraldkeepers · 04/07 11:15
Electrophysiology Market Research Report by Type, by Distribution Channel – Global Forecast to 2025 – Cumulative Impact of COVID-19
Apr 07, 2021 (Heraldkeepers) -- The Global Electrophysiology Market is expected to exceed more than US$ 8.5 Billion by 2024 at a CAGR of 10.6% in the given...
Heraldkeepers · 04/07 11:15
Fluidics for Preclinical Market Overview, Industry Trends and Growing Opportunities Till 2026
Mar 25, 2021 (Market Insight Reports) -- A recent report provides crucial insights along with application based and forecast information in the Global...
Market Insight Reports · 03/25 06:01
Bioreactor Perfusion Systems Market 2021 Industry Share, Size, Growth, SWOT Analysis, Cost Structure, Top Companies, Worldwide Demand, Segments and Forecast Research 2026
Mar 24, 2021 (The Expresswire) -- The report provides revenue of the globalBioreactor Perfusion Systems Market for the period 2016 and 2026, considering 2020...
The Express Wire · 03/24 05:37
Electrophoresis Reagents Market Report - Coronavirus (Covid-19) and the Healthcare Sector During 2025
Mar 22, 2021 (AmericaNewsHour) -- The global Electrophoresis Reagents market was valued at USD 853.26 million in 2016 and is projected to reach USD 1361.60...
AmericaNewsHour · 03/22 07:26
The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18)
Benzinga · 03/19 11:46
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of HBIO. Analyze the recent business situations of Harvard through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average HBIO stock price target is 8.75 with a high estimate of 10.00 and a low estimate of 7.00.
EPS
Institutional Holdings
Institutions: 123
Institutional Holdings: 30.27M
% Owned: 75.83%
Shares Outstanding: 39.93M
TypeInstitutionsShares
Increased
30
1.43M
New
5
57.89K
Decreased
27
1.80M
Sold Out
8
175.72K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.60%
Healthcare Equipment & Supplies
-0.61%
Key Executives
Chairman/President/Chief Executive Officer/Director
James Green
Chief Financial Officer
Michael Rossi
Vice President/General Manager
Kenneth Olson
Lead Director/Independent Director
Bertrand Loy
Vice President/General Manager
Ken Olson
Independent Director
Katherine Eade
Independent Director
Alan Edrick
Independent Director
John Kennedy
Independent Director
Thomas Loewald
Independent Director
Susan Steele
No Data
  • All
  • Financials
  • Insiders
More
About HBIO
Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company's product range is organized into three commercial product families: Cell and Animal Physiology (CAP), Lab Products and Services (LPS), and Molecular Separation and Analysis (MSA). The Company sells these products under brand names, including Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company's products consist of instruments, consumables and systems that are made up of various individual products.

Webull offers kinds of Harvard Bioscience, Inc. stock information, including NASDAQ:HBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HBIO stock methods without spending real money on the virtual paper trading platform.